Abstract
A multidisciplinary team including pediatric transplant surgeons or urologists, pediatric nephrologists, and specialized nurses is needed to provide optimal care after a renal transplant. Perioperative clinical and surgical complications requiring particularly close follow-up include fluid and electrolyte management, blood pressure control, and graft function surveillance. Timely imaging is required in the first postoperative day, using Doppler ultrasound to evaluate for compromised graft blood flow. Immunosuppressive therapy is key to graft survival and is optimized in the initial perioperative period.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bakr MA, Denewar AA, Abbas MH (2016) Challenges for Renal Retransplant: an overview. Exp Clin Transplant 14(Suppl 3):21–26
Brunkhorst LC, Fichtner A, Höcker B, Burmeister G, Ahlenstiel-Grunow T, Krupka K et al (2015) Efficacy and safety of an Everolimus- vs. a mycophenolate Mofetil-based regimen in pediatric renal transplant recipients. PLoS One 10(9):e0135439
Cameron C, Vavilis G, Kowalski J et al (2014) An observational cohort study of the effect of hypertension on the loss of renal function in paediatric kidney recipients. Am J Hypertens 27:579–585
Cameron BM, Kennedy SE, Rawlinson WD, Mackie FE (2016) The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children. Pediatr Transplant 21:1–11
Campos L, Parada B, Furriel F, Castelo D, Moreira P, Mota A (2012) Do intraoperative hemodynamic factors of the recipient influence renal graft function? Transplant Proc 44(6):1800–1803
Dharnidharka VR, Fiorina P, Harmon W (2014) Kidney transplantation in children. N Engl J Med 371:549–558
Drake K, Nehus E, Goebel J (2015) Hyponatremia, hypo-osmolality, and seizures in children early post-kidney transplant. Pediatr Transplant 19:698–703. https://doi.org/10.1111/petr.12575
Faguer S, Kamar N, Guilbeaud-Frugier C et al (2007) Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 83:1277–1280
Ghirardo G, De Franceschi M, Vidal E et al (2014) Transplant renal artery stenosis in children: risk factors and outcome after endovascular treatment. Pediatr Nephrol 29:461
Ghosh PS, Kwon C, Klein M, Corder J, Ghosh D (2014) Neurologic complications following pediatric renal transplantation. J Child Neurol 29(6):793–798
Giussani A, Ardissino G, Belingheri M, Dilena R, Raiteri M, Pasciucco A, Colico C, Beretta C (2016) Posterior reversible encephalopathy syndrome after kidney transplantation in pediatric recipients: two cases. Pediatr Transplant 20:68–71
Grenda R (2015) Biologics in renal transplantation. Pediatr Nephrol 30:1087
Gulhan B, Topaloglu R, Karabulut E et al (2014) Post-transplant hypertension in paediatric kidney transplant recipients. Pediatr Nephrol 29:1075–1080
Guzzo I, Morolli F, Camassei FD et al (2017) Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient. Pediatr Nephrol 32:185
Haas M (2014) An updated Banff schema for diagnosis of antibody mediated rejection in renal allografts. Curr Opin Organ Transplant 19(3):315–322
Hamdani G, Nehus EJ, Hooper DK, Mitsnefes MM (2016) Masked hypertension and allograft function in pediatric and young adults kidney transplant recipients. Pediatr Transplant 20:1026–1031
Hocker B, Zencke S, Krupka K, Fichtner A, Pape L, Dello Strologo L, Guzzo I, Topaloglu R, Kranz B, Konig J, Bald M, Webb NJA, Noyan A, Dursun H, Marks S, Yalcinkaya F, Thiel F, Billing H, Pohl M, Fehrenbach H, Bruckner T, Tonshoff B (2016) Cytomegalovirus infection in pediatric renal transplantation and the impact of chemoprophylaxis with (Val-)ganciclovir. Transplantation 100(4):862–870
Hoorn EJ (2016) Intravenous fluids: balancing solutions. J Nephrol 30:485. [Epub ahead of print]
Jordan CL, Taber DJ, Kyle MO, Connelly J, Pilch NW, Fleming J, Meadows HB, Bratton CF, Nadig SN, McGillicuddy JW, Chavin KD, Baliga PK, Shatat IF, Twombley K (2016) Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant 20:44–48
Kim IK, Choi J, Vo AA, Kang A, Patel M, Toyoda M, Mirocha J, Kamil ES, Louis Cohen J, Louie S, Galera O, Jordan SC, Puliyanda DP (2016) Safety and efficacy of Alemtuzumab induction in highly sensitized pediatric renal transplant recipients. Transplantation 101:883. Publish Ahead of Print
Kim MU, Kim SY, Park YH. A case of tacrolimus-induced encephalopathy after kidney transplantation. Korean J Pediatr 2011;54(1):40–45
Koshy SM, Guttmann A, Hebert D et al (2009) Incidence and risk factors for cardiovascular events and death in paediatric renal transplant patients: a single centre long-term outcome study. Pediatr Transplant 13:1027–1033
Lim WH, McDonald SP, Kennedy SE, Larkins N, Wong G (2016) Association between slow and delayed graft function with graft outcomes in Paediatric and adolescent deceased donor kidney transplant recipients. Transplantation 101:1906
McCoy H (2008) Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care. J Am Acad Nurse Pract 20(2):100–106
Mitsnefes MM, Khoury PR, McEnery PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in paediatric patients. J Pediatr 143:98–103
Mueller T (2007) Mechanisms of action of thymoglobulin. Transplantation 84(11):S5–S10
Ng YW, Singh M, Sarwal MM (2015) Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management. Drugs 75:455
Opelz G, Dohler B (2005) Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 5:2725–2731
Peruzzi L, Amore A, Coppo R (2014) Challenges in pediatric renal transplantation. World J Transplant 4(4):222–228
Pirojsakul K, Desai D, Lacelle C et al (2016) Management of sensitized pediatric patients prior to renal transplantation. Pediatr Nephrol 31:1691
Santoveña AZ, Meseguer CG, Mejia SM, Melgar AA, Camblor CF, Hijosa MM, Carrion AP, Roman LE. BK Virus Infection in Pediatric Renal Transplantation. Transplant Proc. 2015 Jan-Feb;47(1):62–6
Sautenet B, Blancho G, Büchler M et al (2015) One-year results of the effects of rituximab on acute antibody-mediated rejection in renal transplantation: RITUX ERAH, a multicenter double-blind randomized placebo-controlled trial. Transplantation 100:391–399
Seeman T (2009) Hypertension after renal transplantation. Pediatr Nephrol 24:959–972
Sierralta MC, González G, Nome C, Pinilla C, Correa R, Mansilla J, RodrÃguez J, Delucchi A, Ossandón F (2015) Kidney transplant in pediatric patients with severe bladder pathology. Pediatr Transplant 19:675–683
Smith JM (2015) Viral surveillance and subclinical viral infection in pediatric kidney transplantation. Pediatr Nephrol 30:741
Sollinger H et al (2001) Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 72(12):1915–1919
Tai-Heng Chen MD, Wei-Chen Lin MD, Yong-Hao Tseng MD, Chien-Ming Tseng MD, Tai-Tsung Chang MD, Tzeng-Jih Lin MD (2013) Posterior reversible encephalopathy syndrome in children. J Child Neurol 28(11):1378–1386
Taylor K, Kim WT, Maharramova M, Figueroa V, Ramesh S, Lorenzo A (2016) Intraoperative management and early postoperative outcomes of pediatric renal transplants. Paediatr Anaesth 26:987–991
Torricelli FCM, Watanabe A, David-Neto E, Nahas WC (2014) Current management issues of immediate postoperative care in pediatric kidney transplantation. Clinics 69(Suppl 1):39–41
Trachtman H, Frymoyer A, Lewandowski A, Greenbaum L, Feig D, Gipson D, Warady B, Goebel J, Schwartz G, Lewis K, Anand R, Patel U, on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee (2015) Pharmacokinetics, pharmacodynamics, and safety of Lisinopril in pediatric kidney transplant patients: implications for starting dose selection. Clin Pharmacol Ther 98:25–33
Varela-Fascinetto G, Benchimol C, Reyes-Acevedo R, Genevray M, Bradley D, Ives J, Silva HT Jr (2016) Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease. Pediatr Transplant 21:1–11
Verghese PS (2016) Pediatric kidney transplantation: a historical review. Pediatr Res 81:259
Weber LT (2015) Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol 30:253
Weir MR, Burgess ED et al (2015) Assessment and Management of Hypertension in Transplant Patients. JASN 26:1248–1260. Epub ahead of print
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Salas, A., Slamon, N. (2018). Intensive Care of the Child After Kidney Transplantation. In: Dunn, S., Horslen, S. (eds) Solid Organ Transplantation in Infants and Children. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07284-5_79
Download citation
DOI: https://doi.org/10.1007/978-3-319-07284-5_79
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07283-8
Online ISBN: 978-3-319-07284-5
eBook Packages: MedicineReference Module Medicine